Media Summary: Changhoon Yoo, MD, PhD, Asan Medical Center, Seoul, Korea, discusses the use of Unlock the secrets of molecular mechanisms with TissueGnostics' revolutionary Tissue Image Cytometers! Founded in 2003 ... Is the era of cisplatin over, or are we simply becoming more precise about who benefits from it? As perioperative strategies in ...

Advancing Precision Medicine Exploring Ctdna - Detailed Analysis & Overview

Changhoon Yoo, MD, PhD, Asan Medical Center, Seoul, Korea, discusses the use of Unlock the secrets of molecular mechanisms with TissueGnostics' revolutionary Tissue Image Cytometers! Founded in 2003 ... Is the era of cisplatin over, or are we simply becoming more precise about who benefits from it? As perioperative strategies in ... Klaus Pantel, MD, PhD, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany, discusses the emerging role of ... October 28, 2025 - Epigenetic alterations play a pivotal role in cancer biology, and methylation profiling has become a key tool for ... Marina N. Sharifi, MD, University of Wisconsin Carbone Cancer Center, Madison, WI, discusses research in the field of cell-free ...

For our 75th anniversary, we sat down with Dana-Farber leaders, past and present, to gather their reflections on the evolution of ... Listen in as Olga Alexeeva, Director at Personalis, presents NEW ASCO 2025 data on

Photo Gallery

Advancing precision medicine: exploring ctDNA analysis beyond rectal cancer
Advancing Precision Medicine in Lymphoma with ctDNA-MRD - presentation by Dr. Mark Roschewski (NCI)
TissueGnostics in Advancing Precision Medicine & Healthcare 5 Minute Version
Advancing ctDNA as an Early Endpoint Marker in Solid Tumors
Urothelial Carcinoma: Understanding ctDNA & Precision Medicine w/ Drs. Nizam & McGregor | Ep. 287
The role of NGS and ctDNA in advancing personalized medicine in oncology
Advancing Precision Medicine in Oncology
CGC Webinar: Transforming Tumor Methylation Profiling with Oxford Nanopore Direct DNA Sequencing
Advancing precision medicine: cell-free DNA fragment omics in metastatic HER2-negative breast cancer
2025 HOPA Conference:  Utility of Circulating Tumor DNA ctDNA Across the Cancer Care Continuum
The Future of Precision Medicine | Dana-Farber Cancer Institute
ctDNA-based Immunotherapy Monitoring in Advanced Cancer
Sponsored
Sponsored
View Detailed Profile
Advancing precision medicine: exploring ctDNA analysis beyond rectal cancer

Advancing precision medicine: exploring ctDNA analysis beyond rectal cancer

Changhoon Yoo, MD, PhD, Asan Medical Center, Seoul, Korea, discusses the use of

Advancing Precision Medicine in Lymphoma with ctDNA-MRD - presentation by Dr. Mark Roschewski (NCI)

Advancing Precision Medicine in Lymphoma with ctDNA-MRD - presentation by Dr. Mark Roschewski (NCI)

In this recorded presentation from the

Sponsored
TissueGnostics in Advancing Precision Medicine & Healthcare 5 Minute Version

TissueGnostics in Advancing Precision Medicine & Healthcare 5 Minute Version

Unlock the secrets of molecular mechanisms with TissueGnostics' revolutionary Tissue Image Cytometers! Founded in 2003 ...

Advancing ctDNA as an Early Endpoint Marker in Solid Tumors

Advancing ctDNA as an Early Endpoint Marker in Solid Tumors

Circulating tumor DNA

Urothelial Carcinoma: Understanding ctDNA & Precision Medicine w/ Drs. Nizam & McGregor | Ep. 287

Urothelial Carcinoma: Understanding ctDNA & Precision Medicine w/ Drs. Nizam & McGregor | Ep. 287

Is the era of cisplatin over, or are we simply becoming more precise about who benefits from it? As perioperative strategies in ...

Sponsored
The role of NGS and ctDNA in advancing personalized medicine in oncology

The role of NGS and ctDNA in advancing personalized medicine in oncology

Klaus Pantel, MD, PhD, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany, discusses the emerging role of ...

Advancing Precision Medicine in Oncology

Advancing Precision Medicine in Oncology

Jerome Madison, Host of The

CGC Webinar: Transforming Tumor Methylation Profiling with Oxford Nanopore Direct DNA Sequencing

CGC Webinar: Transforming Tumor Methylation Profiling with Oxford Nanopore Direct DNA Sequencing

October 28, 2025 - Epigenetic alterations play a pivotal role in cancer biology, and methylation profiling has become a key tool for ...

Advancing precision medicine: cell-free DNA fragment omics in metastatic HER2-negative breast cancer

Advancing precision medicine: cell-free DNA fragment omics in metastatic HER2-negative breast cancer

Marina N. Sharifi, MD, University of Wisconsin Carbone Cancer Center, Madison, WI, discusses research in the field of cell-free ...

2025 HOPA Conference:  Utility of Circulating Tumor DNA ctDNA Across the Cancer Care Continuum

2025 HOPA Conference: Utility of Circulating Tumor DNA ctDNA Across the Cancer Care Continuum

Learning Objectives: Describe

The Future of Precision Medicine | Dana-Farber Cancer Institute

The Future of Precision Medicine | Dana-Farber Cancer Institute

For our 75th anniversary, we sat down with Dana-Farber leaders, past and present, to gather their reflections on the evolution of ...

ctDNA-based Immunotherapy Monitoring in Advanced Cancer

ctDNA-based Immunotherapy Monitoring in Advanced Cancer

Listen in as Olga Alexeeva, Director at Personalis, presents NEW ASCO 2025 data on

Advancing Equity in Precision Oncology - Christopher Li, MD, PhD - SCHD26

Advancing Equity in Precision Oncology - Christopher Li, MD, PhD - SCHD26

Advancing